Dermata Therapeutics (DRMAW) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-4.5
-3.45
-2.39
-1.34

Details

Expected EPS
-2.9
Actual EPS
-1.66
Surprise EPS
1.24
Surprise Percent
+42.76%

Description

Dermata Therapeutics (DRMAW) has reported earnings of -1.66 per share for Q3 2025.

0 Comments

Share your thoughts